Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2004-09-06
2009-12-01
Chernyshev, Olga N. (Department: 1649)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
Reexamination Certificate
active
07625711
ABSTRACT:
The present invention provides a novel drug/agent for the prevention and/or treatment of Alzheimer's disease based on a different Alzheimer's disease onset mechanism from the amyloid hypothesis, and a method of screening for it.
REFERENCES:
patent: 2003/0022171 (2003-01-01), Sudhof et al.
patent: 2003/0108929 (2003-06-01), Sudhof et al.
patent: 2003/0134323 (2003-07-01), Sudhof et al.
patent: WO 02/79500 (2002-10-01), None
Kinoshita et al. Journal of Biological Chemistry, 277: 28530-28536, (2002).
Xu et al. Proceedings of the National Academy of Sciences, USA, 96:7547-7552, (1999).
Chen et al. Journal of Cell Biology 163(1): 27-33, (2003).
Alves da Costa et al. The Journal of Neuroscience, 26(23):6377-6385, Jun. 2006.
Vickers, Drugs Aging, 19(7):487-494, 2002.
Donaldson et al. PNAS, 99(22):14053-14058, Oct. 2002.
Pritchard JF, BMC Neuroscience, 9 Suppl 3:S1, Dec. 2008.
T. Tomita at al., An amyloid hypothesis and Aβ42; Cell Technology, vol. 20, No. 11, pp. 1489-1494 (2001).
Xinwei Cao et al., “A transcriptively active complex of APP with Fe65 and histone acetyltransferase tip60,” Science. vol. 293, pp. 115-120 (Jul. 2001).
Park et al., “Involvement of p53, JNK and NF-κB in CT-induced neuronal apoptosis,” Society for Neuroscience Abstracts, vol. 27, No. 1, p. 1439 (2001).
Ayae Kinoshita at al., “The γ secretase-generated carboxyl-terminal domain of the amyloid precursor protein Induces apoptosis via tip60 in H4 cells,” J. Biol. Chem., vol. 277, No. 32, pp. 28530-28536 (Aug. 2002).
Sionov at al., “ The cellular response to p53: the decision between life and death,” Oncogene, vol. 18, No. 45, pp. 6145-6157 (1999).
Yoichi Araki et al., “Coordinated metabolism of alcadein and amylold β-protein precursor regulates FE65-dependent gene transactivation,” J. Biol. Chem., vol. 279, No. 23, pp. 24343-24354, (Jun. 2004).
“The β-Amyloid Precursor Protein APP is Tyrosine-Phosphorylated in Cells Expressing a Constitutively Active Form of the Abl Protoncogene”, Zambrano, N. et al, Journal of Biological Chemistry, vol. 276, No. 23, ISSN: 0021-9258, Jun. 8, 2001, p19787-p19792, XP002530714.
“The c-Abl Tyrosine Kinase Phosphorylates the Fe65 Adaptor Protein to Stimulate Fe65/Amyloid Precursor Protein Nuclear Signaling”, Perkinton, M. S. et al, Journal of Biological Chemistry, vol. 279, No. 21, ISSN: 0021-9258, Apr. 18, 2004, p22084- p22091, XP002530715.
P4-299, “Presenilin-Dependent Gamma-Secretase Cleavage of Alcadein and Amyloid Precursor Protein: Their Coordinative Metabolism and Cooperative Regulation on FE65-dependent Gene Transactivation”, Araki, Y.et al, Neurobiology of Aging, vol. 25, ISSN: 0197-4580, Jul. 1, 2004, p5560, XP004626471.
“The Transcriptional Activity of the APP Intracellular Domain-Fe65 Complex is Inhibited by Activation of the NF-κB Pathway”, Zhao, Q. et al, Biochemistry, vol. 42, No. 12, ISSN: 0006-2960, Aug. 3, 2003, p3627-p3634, XP002530716.
“The Intracellular Domain of the Low Density Lipoprotein Receptor-Related Protein Modulates Transactivation Mediated by Amyloid Precursor Protein and Fe65”, Kinoshita, A. et al, Journal of Biological Chemistry, vol. 278, No. 42, ISSN: 0021-9258, Jul. 29, 2003, p41182-p41188, XP002480007.
“Activation of the Neuronal c-Abl Tyrosine Kinase by Amyloid-β-Peptide and Reactive Oxygen Species”, Alvarez, A. R. et al, Neurobiology of Disease, vol. 17, No. 2, ISSN: 0969-9961, Nov., 2004, p326-p336, XP002530717.
European Search Report dated Jun. 18, 2009.
Nakagawara Akira
Ozaki Toshinori
Chernyshev Olga N.
Hisamitsu Pharmaceutical Co. Inc.
MacFarlane Stacey
Sughrue & Mion, PLLC
LandOfFree
Screening method for the identification of a drug for the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Screening method for the identification of a drug for the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Screening method for the identification of a drug for the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4100339